Indication

Enterobacter joint infection

An Enterobacter joint infection is an acute or subacute septic arthritis caused by Gram-negative bacilli of the genus *Enterobacter*, most commonly *Enterobacter cloacae*. Read more about Enterobacter joint infection

119 drugs 69 manufacturers

Advertisement

Drugs that treat it

Common Enterobacter joint infection therapies.

Showing 55–63 of 119 drugs

Filter & compare in the drug finder →Opens the drug finder with Enterobacter joint infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Enterobacter joint infection.

An Enterobacter joint infection is an acute or subacute septic arthritis caused by Gram-negative bacilli of the genus *Enterobacter*, most commonly *Enterobacter cloacae*.

This condition affects the synovial membrane and intra-articular fluid of native or prosthetic joints within the musculoskeletal system, occurring predominantly in older adults, immunocompromised individuals, or patients with recent orthopedic surgery, trauma, or nosocomial bacteremia.

Pathophysiologically, bacterial proliferation within the joint cavity triggers an intense neutrophilic inflammatory response, resulting in joint effusion, severe pain, limited range of motion, and rapid enzymatic degradation of articular cartilage and adjacent bone.

Clinical management is often complicated by the pathogen's capacity for inducible chromosomal AmpC beta-lactamase production, conferring resistance to multiple standard beta-lactam therapies.

Personalize your experience

Follow Enterobacter joint infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it